Cargando…
Allogeneic Hematopoietic Stem Cell Transplantation in Severe Aplastic Anemia: A Single Centre Experience in Malaysia
BACKGROUND: Hematopoietic stem cell transplantation (HSCT) provides curative therapy in almost 90% of patients with severe aplastic anemia (SAA). Older age, long duration of disease with consequent heavy exposure to transfusion, and active infection at the time of HSCT have a negative influence on t...
Autores principales: | Wilfred, Gilbert, Ong, Tee Chuan, SH Shahnaz, Syed Abd Kadir, Wah, Ho Kim, Carlo, Edmund Syed, Jameela, Sathar, Mui Tan, Sen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Asia-Pacific Blood and Marrow Transplantation Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9870683/ https://www.ncbi.nlm.nih.gov/pubmed/36710947 http://dx.doi.org/10.31547/bct-2021-018 |
Ejemplares similares
-
Very severe aplastic anemia in an 80‐year‐old man
por: Kasinathan, Ganesh, et al.
Publicado: (2021) -
Immune Reconstitution in Pediatric Aplastic Anemia after Allogeneic Hematopoietic Stem-cell Transplantation
por: Wang, Jiayu, et al.
Publicado: (2022) -
Population pharmacokinetics of fludarabine in patients with aplastic anemia and Fanconi anemia undergoing allogeneic hematopoietic stem cell transplantation
por: Mohanan, E, et al.
Publicado: (2017) -
Co-occurrence of Multiple Sclerosis and Severe Aplastic Anemia: A Report of Two Cases Successfully Treated with Allogeneic Hematopoietic Stem Cell Transplantation
por: Haroon, Alfadil, et al.
Publicado: (2023) -
Correction: Population pharmacokinetics of fludarabine in patients with aplastic anemia and Fanconi anemia undergoing allogeneic hematopoietic stem cell transplantation
por: Mohanan, E., et al.
Publicado: (2018)